Overview
Biotechnology and pharmaceutical manufacturers must recognize, understand, and address many legal and regulatory requirements associated with the research, development, pricing, promotion, marketing, and selling of their respective services and products—domestically and internationally.
The biotechnology and pharmaceutical industries continue to receive significant scrutiny from the public; federal, state, and international regulators; elected officials; and enforcement agencies. Therefore, entities operating in these industries must remain even more vigilant and knowledgeable about the legal and regulatory parameters affecting their companies to stay compliant and proactive and minimize risk.
Epstein Becker Green counsels companies and institutions operating in the different segments of biotechnology and pharmaceutical industries domestically and internationally. We provide comprehensive legal services relating to all aspects of the development of products, the U.S. Food and Drug Administration (FDA) regulatory approval process, government and third-party reimbursement concerns, and post-approval marketing, commercialization, and compliance requirements. Firm attorneys publish and present extensively at leading industry events and work actively on behalf of firm clients to both educate and advocate to federal and state government agencies and regulators on significant industry issues.
Services/Scope of Practice
Development of Life Science Products and FDA Regulatory Approval
- Providing FDA counseling relating to clinical trial registries and databases, grant-making procedures, and relationships with physicians investigators, and research institutions
- Developing and negotiating co-development, co-promotion, outsourcing, and other strategic research, development, and collaboration agreements
- Providing FDA counseling relating to labeling and advertising claims
Government and Third-Party Reimbursement
- Counseling on government pricing programs, including Medicaid Best Price, Average Sales Price, Competitive Acquisition Program, the Federal Supply Schedule, and the Public Health Service Act, as well as on VA pricing issues
- Providing counseling and strategic planning assistance regarding federal and state drug and device reimbursement programs
- Advising on the processes and strategies for obtaining coverage, coding, and payment for drugs and devices by government and private payors
- Providing regulatory counseling regarding product discount/rebate arrangements with distributors, group purchasing organizations, managed care organizations, long-term care facilities, physicians, institutions, specialty pharmaceutical suppliers, federal and state purchasers (including state pharmaceutical assistance programs (or "SPAPs") and other state and federal pharmaceutical programs), and other purchasers
- Providing antitrust counsel related to manufacturer pricing issues
- Counseling on license agreements and co-promotional activities
Post-Approval Marketing, Commercialization, and Compliance
- Providing all facets of fraud and abuse counseling to manufacturers and their direct and indirect customers and/or purchasers relating to sales programs, marketing initiatives, and other collaborative programs and relationships, including disease management, medication therapy management, coupons, samples and sample cards, reimbursement support, grants, and patient assistant programs
- Providing advice relating to all aspects of health reform regulations, including the Sunshine Act and state reporting laws
- Supporting and counseling on manufacturer new product launches
- Providing health regulatory counsel relating to distribution and fee-for-service arrangements with managed care plans and consumers
- Providing FDA counseling relating to promotional matters, non-promotional activities, continuing medical education activities, and good clinical and laboratory practices
- Providing all facets of counsel regarding post-market clinical trial research programs and grant administration
- Counseling on licensure and other accreditation standards
- Providing HIPAA privacy and security counseling relating to manufacturing, research, and marketing issues
Investigations, Litigation, and Administrative Matters
- Defending manufacturers in connection with false claim qui tam actions and other federal, state, and congressional health care fraud investigations and inquiries
- Negotiating corporate integrity agreements (CIAs) with the U.S. Department of Health and Human Services' Office of Inspector General (OIG)
- Assisting with the implementation and monitoring of CIA compliance
- Providing counsel regarding the submission of voluntary disclosures to the OIG and/or other relevant regulators
- Defending manufacturers and their research partners in private actions related to clinical trial noncompliance and misconduct
- Preparing and assisting manufacturers for appearances at FDA administrative hearings
- Assisting manufacturers in responding to warning letters, notice-of-violation letters, and congressional inquiries
Corporate Compliance
- Developing and implementing all aspects of corporate compliance programs for manufacturers and their direct and indirect customers
- Conducting corporate effectiveness reviews/assessments of corporate compliance programs
- Developing training programs on corporate compliance for marketing and sales forces
- Assisting with the development of reporting systems and compliance monitoring and auditing priorities
- Assisting manufacturers with gap assessments and Board assessments
- Providing counsel in connection with internal compliance investigations
- Developing clinical trial research corporate compliance programs for manufacturers, clinical research organizations, and site management organizations, including compliance with Good Clinical Practices, human subject protection compliance procedures, and procedures regarding investigator-initiated research
- Developing research compliance programs addressing relationships with research sites, researchers, vendors, professional organizations, independent foundations, and other participants in the clinical research process
Policy and Legislation
- Monitoring and analyzing pending federal and state legislation, rulemaking, regulations, and guidance
- Providing assistance with the submission of comments in connection with pending legislation and proposed rules, regulations, and guidance
- Assisting with the preparation of testimony in connection with pending legislation
- Providing counsel regarding federal and state marketing, disclosure, sales, gifts, compliance programs, pricing, clinical trials, pedigree, and related reporting requirements
- Providing legislative industry updates and analyses
Federal and State Transparency Reporting
- Counseling clients on federal and state reporting requirements
- Conducting gap assessments
- Correcting compliance implementation deficiencies
- Addressing infrastructure and resource matters
- Implementing aggregate spend reporting systems
- Drafting policies, procedures, and working instructions
- Training employees, vendors, and health care professionals
- Responding to government agencies and proposed regulations
- Analyzing preemption matters
- Informing clients of federal and state law developments
Read less
Focus Areas
Services
Industries
Trending Issues
Experience
Contacts
- Member of the Firm
- Board of Directors / Member of the Firm
- Member of the Firm
Media
Events
Upcoming Events
Past Events
Insights
Insights
- Media CoverageKate Heffernan Quoted in “Colleges Get More Leeway to Handle Research Misconduct”2 minute read
- Media CoverageRichard Hughes Quoted in “CMS Signals Preventive Services Coverage Update with Pending Rule”3 minute read
- Media CoverageBBA Spotlight Series: Get to Know Emerging Leaders in Boston Law–Marylana Saadeh Helou8 minute read
- Media Coverage
Richard Hughes Quoted in “DOJ Will Ask SCOTUS to Take Up Braidwood”
3 minute read - PublicationsInteragency Strike Force on Unfair and Illegal Pricing Holds First Public Meeting1 minute read
- Media CoverageChristopher Smith Quoted in “HDA 2024 Traceability Seminar: A Legal Perspective Regarding DSCSA”5 minute read
- PublicationsFTC Releases Controversial Interim Staff Report on PBMs’ Purported Impact on Drug Prices3 minute read
- Media CoverageJames Boiani Quoted in “CMS Takes Baby Steps in New 'Breakthrough' Device Policy”2 minute read
- PublicationsProposed FTC Budget Signals Continued Enforcement Initiatives2 minute read
- BlogsPodcast: The DEA Is Knocking at Your Door . . . Are You Prepared? – Diagnosing Health Care2 minute read
- BlogsFDA Guidance on DSCSA Small Dispenser Exemption and Exemptions and Waivers for Other Trading Partners13 minute read
- BlogsPodcast: The Future of Laboratory Testing Just Got a Little Clearer - FDA's Final Rule on LDTs – Diagnosing Health Care2 minute read
- Media CoverageDavid Shillcutt Quoted in “Illinois Bans Step Therapy, Health Plan Prior Authorization for Emergency Mental Health ...3 minute read
- PublicationsFDA Issues Long-Anticipated Draft Guidance on Diversity Action Plans16 minute read
- PublicationsNew Anti-Obesity Medications Should Be Considered Preventive Health Care2 minute read
- PublicationsVaccine Politics4 minute read
- PublicationsBraidwood v Becerra: The Threat to Preventive Services Just Got Worse3 minute read
- Media Coverage
Richard Hughes Quoted in “Supreme Court Overrules Chevron Deference, Dealing Blow to Federal Healthcare Agencies” ...
3 minute read - Media CoverageRichard Hughes Quoted in “Feds' 5th Circ. Win on Preventive Care May Imperil ACA”3 minute read
- Media CoverageRichard Hughes Quoted in “Obamacare Mandate Battle Shifts After Appeals Court Speaks”3 minute read
- Firm Announcements
Elizabeth Scarola Named to the 2024 Florida Rising Stars List
7 minute read - Media CoverageRichard Hughes Quoted in “Court Upholds ACA’s Free Preventive Services Mandate”3 minute read
- Media CoverageRichard Hughes Quoted in “‘A Mixed Bag’: Fifth Circuit Rules on ACA Preventive Services Legal Case”3 minute read
- Media CoverageRichard Hughes Quoted in “News Briefs: Court Upholds ACA Preventive Services Coverage Mandate, for Now”2 minute read
- Media CoverageRichard Hughes Quoted in “Appeals Court Finds 'Obamacare' Pillar Unconstitutional in Suit Over HIV-Prevention Drug” ...3 minute read
- Media CoverageRichard Hughes Quoted in “Fifth Circuit Maintains ACA Preventive Mandate; but Remands Vaccine, Birth Control” ...1 minute read
- Media CoverageErin Sutton Quoted in “SCOTUS Mifepristone Ruling Leaves Employers in Coverage Quandary”3 minute read
- BlogsPodcast: If Cannabis Is Reclassified, What Will Happen to the Marketplace? – Diagnosing Health Care2 minute read
- Media CoverageGeorge Breen Quoted in “High Court Petition Asks Justices: What's a 'Willful' Kickback?”3 minute read
- PublicationsImplications for Pharmacies Navigating Shared Clinical Decision-Making in Vaccination2 minute read
- Media CoverageBradley Merrill Thompson Cited in “AI Regulation: Global Picture Balances Innovation and Insight”3 minute read
- Media CoverageBradley Merrill Thompson Quoted in “Experts Advise Against Prescriptive FDA Policies for Regulating AI”3 minute read
- PublicationsThe Supreme Court and the Future of Expert Preventive Recommendations2 minute read
- Media CoverageGeorge Breen Quoted in “Custom Drug Makers Stay on DOJ Radar in Fla. Fraud Case”2 minute read
- BlogsPodcast: Unveiling Gender-Affirming Care: Why It Matters and What’s at Stake – Diagnosing Health Care2 minute read
- Blogs
Litigating Nutrition: Class Action Battles Over Dietary Supplements – Speaking of Litigation Video Podcast
41 minute read - Media CoverageJames Boiani Quoted in “Jazz Pharma to Fight FDA in Court Over Rival Sleep Drug Approval”5 minute read
- PublicationsThe IRA: Reducing Inflation or Threatening Patient Access?2 minute read
- Media CoverageGeorge Breen Quoted in “Supreme Court Ruling Changes View of Wrongful Intent”5 minute read
- PublicationsThe Path to Prevention: Charting the Course for a Healthier Nation2 minute read
- PublicationsFive Commissioners and a Vote on Noncompetes to Come2 minute read
- PublicationsThe Vaccine Pricing Assault That Threatens Public Health3 minute read
- Media CoverageTheodora McCormick Quoted in “‘Vague’ NY Law Looms for the Vitamin Shoppe, Other Supplement Retailers”3 minute read
- Media CoverageTeddy McCormick Quoted in “NPA to Seek Injunction Against NY Law Related to Weight Loss Supplements”4 minute read
- PublicationsFTC Continues Investigation into PBM Practices2 minute read
- BlogsFDA Releases Draft Guidance on New Dietary Ingredient Notification Procedures, Timelines11 minute read
- PublicationsFDA and OHRP Issue Joint Draft Guidance on Content, Organization, and Presentation of Consent Forms for Research ...9 minute read
- Firm AnnouncementsEpstein Becker Green Continues to Materially Expand Employee Benefits and Executive Compensation Capabilities with ...3 minute read
- Publications
Will Religious Freedom Claims Trump Public Health? Braidwood and HIV Prevention
2 minute read - Media CoverageRichard Hughes Quoted in “ObamaCare Faces Key Hearing After Texas Ruling”2 minute read